 |
PDBsum entry 2xbw
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Blood clotting
|
PDB id
|
|
|
|
2xbw
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
|
|
Key reference
|
|
|
Title
|
|
Discovery of a factor xa inhibitor (3r,4r)-1-(2,2-Difluoro-Ethyl)-Pyrrolidine-3,4-Dicarboxylic acid 3-[(5-Chloro-Pyridin-2-Yl)-Amide] 4-[[2-Fluoro-4-(2-Oxo-2h-Pyridin-1-Yl)-Phenyl]-Amide] as a clinical candidate.
|
|
|
Authors
|
|
L.Anselm,
D.W.Banner,
J.Benz,
K.G.Zbinden,
J.Himber,
H.Hilpert,
W.Huber,
B.Kuhn,
J.L.Mary,
M.B.Otteneder,
N.Panday,
F.Ricklin,
M.Stahl,
S.Thomi,
W.Haap.
|
|
|
Ref.
|
|
Bioorg Med Chem Lett, 2010,
20,
5313-5319.
|
|
|
PubMed id
|
|
|
|
|
|
Abstract
|
|
|
No abstract given.
|
|
|
|
|
|
|
